Impact of High-Carbohydrate Diet on Metabolic Parameters in Patients with Type 2 Diabetes.

Existing Reviews

Please note, new claims can take a short while to show up.

No claims yet.

Annotation Summary

Term Occurence Count Dictionary
type 2 diabetes mellitus 1 endocrinologydiseases
diabetes mellitus 1 endocrinologydiseases
hyperinsulinemia 2 endocrinologydiseases
hypertriglyceridemia 1 endocrinologydiseases
metabolic syndrome 1 endocrinologydiseases
metformin 1 endocrinologydiseasesdrugs
obesity 2 endocrinologydiseases

Graph of close proximity drug and disease terms (within 200 characters).

Note: If this graph is empty, then there are no terms that meet the proximity constraint.

Review

Having read the paper, please pick a pair of statements from the paper to indicate that a drug and disease are related.

Select Drug Character Offset Drug Term Instance
metformin 10795 baseline during the study. Furthermore, they reported about taking DM medication, including insulin, metformin and sulfonylurea and no difference between the two diets at the baseline and during the study period.
Select Disease Character Offset Disease Term Instance
diabetes mellitus 605 KoreaPublication date (epub): 3/2017Publication date (collection): 4/2017AbstractIn patients with type 2 diabetes mellitus (T2DM), whether dietary carbohydrates have beneficial or detrimental effects on cardiometabolic risk
hyperinsulinemia 2970 and T2DM, have increased, and untoward effects of HC diet, such as postprandial glucose elevation, hyperinsulinemia and lipid concern (increasing triglycerides and decreasing HDL-C), also made a reappraisal of a low-carbohydrate
hyperinsulinemia 45988 diets may attenuate these adaptations, facilitating long-term weight-loss maintenance and reducing hyperinsulinemia (the carbohydrate-insulin model) [[93]]. The conflicting results of studies on HC diets are largely
hypertriglyceridemia 24730 with a higher carbohydrate intake (% of total energy intake: 58.5% vs. 52.4% vs. 53.1%, p = 0.04) and hypertriglyceridemia (194 vs. 169 vs. 150 mg/dL, p = 0.02) than other genotype carriers (Ile/Ile or Ile/Val) among the population
metabolic syndrome 37533 MADIAB (Macrobiotic Diet on the improvement of metabolic control in patients with type 2 diABetes and metabolic syndrome ) trial was conducted in patients with T2DM comparing the Ma-Pi (Mario Pianesi) 2 diet (C:F:P = 73%:15.2%:11.8%,
obesity 2863 CVD [[3],[4],[5],[6],[7]]. However, despite this trend, the prevalence of metabolic diseases, such as obesity and T2DM, have increased, and untoward effects of HC diet, such as postprandial glucose elevation, hyperinsulinemia
obesity 8595 ‘cholesterol’, ‘triglyceride’, ‘HDL-cholesterol’, ‘LDL-cholesterol’, ‘body weight’ and ‘ obesity ’. The search was limited to studies written in the English language and adults above 19 years.3.1.
type 2 diabetes mellitus 598 152-050, KoreaPublication date (epub): 3/2017Publication date (collection): 4/2017AbstractIn patients with type 2 diabetes mellitus (T2DM), whether dietary carbohydrates have beneficial or detrimental effects on cardiometabolic risk

You must be authorized to submit a review.